Metabolic R&D platform for preclinical drug development
Date: 21.3.2014
Technology offer: Metabolic R&D platform for preclinical drug development
Reference: TOHU20131210003
Summary: A privately owned Hungarian SME is offering innovative and cost-effective preclinical R&D services focusing on metabolic diseases (diabetes, hyperlipidemia, atherosclerosis, obesity, uremia) efficacy, safety, and pharmacokinetic animal models, including co-morbidity, custom designed and large animal models as well. The company is looking for partners that are interested in out-sourcing their preclinical pharmacology projects. The company is open for joint venture or technical cooperation.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
